欧林生物
(688319)
| 流通市值：112.30亿 | | | 总市值：112.30亿 |
| 流通股本：4.05亿 | | | 总股本：4.05亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 232,679,319.22 | 192,296,155.2 | 246,608,575.54 | 169,670,167.26 |
| 交易性金融资产 | 2,600,000 | 2,600,000 | 2,600,000 | 47,600,000 |
| 应收票据及应收账款 | 747,374,346.99 | 709,195,372.65 | 655,974,993.78 | 665,082,511.8 |
| 其中：应收票据 | 1,645,600 | 2,630,000 | 404,608.88 | 168,000 |
| 应收账款 | 745,728,746.99 | 706,565,372.65 | 655,570,384.9 | 664,914,511.8 |
| 预付款项 | 7,124,970.08 | 4,339,030.61 | 6,569,598.04 | 9,384,798.72 |
| 其他应收款合计 | 1,739,106.65 | 2,175,655.49 | 2,575,050.67 | 2,623,482.62 |
| 存货 | 60,593,053.71 | 66,456,039.67 | 62,383,250.35 | 68,803,356.79 |
| 其他流动资产 | 23,179,230.83 | 21,692,988.63 | 19,622,044.56 | 1,059,401.37 |
| 流动资产合计 | 1,075,290,027.48 | 998,755,242.25 | 996,333,512.94 | 964,223,718.56 |
| 非流动资产: | | | | |
| 固定资产 | 401,387,302.25 | 406,781,428.62 | 393,016,663.17 | 390,396,357.92 |
| 在建工程 | 210,839,406.01 | 203,688,292.08 | 226,258,725.96 | 200,612,663.22 |
| 使用权资产 | 8,302,058.94 | 10,315,430.68 | 11,395,862.02 | 12,476,293.36 |
| 无形资产 | 16,525,482.34 | 16,556,658.51 | 16,899,398.35 | 17,242,138.35 |
| 开发支出 | 353,711,691.93 | 353,650,677.34 | 348,555,954.62 | 330,915,866.8 |
| 长期待摊费用 | 4,300,242.94 | 5,040,538.72 | 5,486,226.17 | 5,809,678.74 |
| 递延所得税资产 | 28,996,198.98 | 24,905,439.79 | 24,905,439.79 | 22,715,457.93 |
| 其他非流动资产 | 363,321.1 | 218,000 | 218,000 | 577,465 |
| 非流动资产合计 | 1,024,425,704.49 | 1,021,156,465.74 | 1,026,736,270.08 | 980,745,921.32 |
| 资产总计 | 2,099,715,731.97 | 2,019,911,707.99 | 2,023,069,783.02 | 1,944,969,639.88 |
| 流动负债: | | | | |
| 短期借款 | 50,000,000 | 30,000,000 | 30,000,000 | 20,000,000 |
| 应付票据及应付账款 | 145,612,502.64 | 141,302,018.42 | 153,068,762.45 | 116,333,283.38 |
| 应付账款 | 145,612,502.64 | 141,302,018.42 | 153,068,762.45 | 116,333,283.38 |
| 合同负债 | 3,905,237.17 | 941,314.56 | 986,426.8 | 2,115,824.76 |
| 应付职工薪酬 | 1,774,589.46 | 204,496.46 | 16,116,721.98 | 434,378 |
| 应交税费 | 15,718,730.77 | 14,702,863.08 | 3,644,755.72 | 9,116,387.4 |
| 其他应付款合计 | 466,983,685.53 | 444,823,609.47 | 461,171,494.02 | 405,672,924.18 |
| 一年内到期的非流动负债 | 151,785,787.06 | 105,058,572.49 | 72,055,470.64 | 78,698,512.22 |
| 其他流动负债 | 507,680.83 | 28,239.44 | 29,592.8 | 18,032.24 |
| 流动负债合计 | 836,288,213.46 | 737,061,113.92 | 737,073,224.41 | 632,389,342.18 |
| 非流动负债: | | | | |
| 长期借款 | 317,548,288.4 | 296,316,528.4 | 323,716,528.4 | 289,331,528.4 |
| 租赁负债 | 4,770,678.36 | 3,556,197.21 | 7,258,321.88 | 8,646,041.99 |
| 预计负债 | 17,831,738.05 | 14,460,591.59 | 13,484,801.75 | 11,653,604.32 |
| 递延收益 | 43,387,931.46 | 28,945,275.85 | 29,162,620.24 | 26,354,964.63 |
| 递延所得税负债 | 10,562,994.29 | 8,394,587.42 | 8,394,587.42 | 8,255,815.87 |
| 非流动负债合计 | 394,101,630.56 | 351,673,180.47 | 382,016,859.69 | 344,241,955.21 |
| 负债合计 | 1,230,389,844.02 | 1,088,734,294.39 | 1,119,090,084.1 | 976,631,297.39 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 405,409,300 | 405,708,900 | 405,708,900 | 405,933,600 |
| 资本公积 | 556,212,746.06 | 560,578,168.37 | 560,578,168.37 | 593,690,397.97 |
| 减:库存股 | - | 3,172,764 | 3,172,764 | 5,561,325 |
| 盈余公积 | 18,192,083.14 | 18,192,083.14 | 18,192,083.14 | 14,198,275.26 |
| 未分配利润 | -110,488,241.25 | -50,438,351.86 | -77,627,668.73 | -48,414,233.4 |
| 归属于母公司股东权益合计 | 869,325,887.95 | 930,868,035.65 | 903,678,718.78 | 959,846,714.83 |
| 少数股东权益 | - | 309,377.95 | 300,980.14 | 8,491,627.66 |
| 股东权益合计 | 869,325,887.95 | 931,177,413.6 | 903,979,698.92 | 968,338,342.49 |
| 负债和股东权益合计 | 2,099,715,731.97 | 2,019,911,707.99 | 2,023,069,783.02 | 1,944,969,639.88 |
| 公告日期 | 2026-08-18 | 2026-04-30 | 2026-03-31 | 2025-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |